Kais Mnafgui Selected Research

Kais Mnafgui Research Topics

Disease

12	Myocardial Infarction 11/2022 - 11/2013
7	Body Weight (Weight, Body) 01/2022 - 01/2012
6	Necrosis 01/2022 - 10/2016
4	Hypertension (High Blood Pressure) 08/2016 - 12/2011
3	Cardiomegaly (Heart Hypertrophy) 12/2021 - 08/2020
3	Inflammation (Inflammations) 10/2021 - 03/2014
2	Infarction (Infarctions) 11/2022 - 08/2021
2	Ischemic Stroke 12/2021 - 08/2021
2	Cardiotoxicity 10/2021 - 02/2020
2	Ventricular Remodeling 10/2017 - 10/2016
1	Atrial Flutter (Flutter, Atrial) 12/2021
1	Stroke (Strokes) 12/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Hyponatremia 08/2021
1	Brain Ischemia (Cerebral Ischemia) 08/2021
1	Brain Edema (Cerebral Edema) 08/2021
1	Thrombosis (Thrombus) 08/2020
1	Edema (Dropsy) 01/2020
1	Heart Injuries 01/2020
1	Spasm (Spasms) 08/2016
1	Diarrhea 08/2016
1	Obesity 07/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2013
1	Hyperglycemia 01/2013

Drug/Important Bio-Agent (IBA)

12	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2022 - 01/2015
9	EnzymesIBA 08/2021 - 12/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
6	Troponin T (Troponin T1)IBA 12/2021 - 06/2015
5	coumarinIBA 01/2022 - 10/2019
5	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2020
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2021 - 01/2015
5	LipidsIBA 01/2020 - 03/2014
3	AcenocoumarolIBA 12/2021 - 01/2020
3	Glutathione PeroxidaseIBA 08/2021 - 10/2016
3	Lipase (Acid Lipase)FDA Link 08/2016 - 01/2012
2	Clopidogrel (Plavix)FDA Link 01/2022 - 10/2016
2	Biological ProductsIBA 01/2022 - 07/2015
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2019
2	Superoxide DismutaseIBA 08/2021 - 10/2016
2	Thiobarbituric Acid Reactive SubstancesIBA 08/2021 - 10/2016
2	oleuropeinIBA 08/2021 - 01/2015
2	oxidized low density lipoproteinIBA 01/2020 - 01/2012
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 06/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019 - 06/2015
2	Alanine Transaminase (SGPT)IBA 10/2019 - 06/2015
2	MB Form Creatine KinaseIBA 10/2019 - 06/2015
2	EugenolIBA 10/2016 - 12/2013
2	AlloxanIBA 08/2016 - 12/2013
2	Volatile Oils (Essential Oils)IBA 08/2016 - 12/2011
2	CarbohydratesIBA 03/2014 - 12/2011
1	Vitamin K FDA Link 12/2021
1	Caspase 3 (Caspase-3)IBA 10/2021
1	Permethrin (Ambush)FDA LinkGeneric 10/2021
1	Neuroprotective AgentsIBA 08/2021
1	CatalaseIBA 08/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2021
1	Superoxides (Superoxide)IBA 06/2021
1	AntioxidantsIBA 06/2021
1	HDL LipoproteinsIBA 06/2021
1	AnticoagulantsIBA 08/2020
1	cypermethrin (alphamethrin)IBA 02/2020
1	(E)- N'- (1- (7- hydroxy- 2- oxo- 2H- chromen- 3- yl) ethylidene) benzohydrazideIBA 01/2020
1	trans-crotonin (CTN)IBA 01/2020
1	HydrazonesIBA 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2016
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 04/2016
1	cinnamic acidIBA 07/2015
1	Antihypertensive Agents (Antihypertensives)IBA 07/2015
1	PhytochemicalsIBA 07/2015
1	Linseed Oil (Flaxseed Oil)IBA 06/2015
1	Alkaline PhosphataseIBA 06/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2014
1	trigonellineIBA 01/2013
1	LeptinIBA 01/2012
1	FlavonoidsIBA 01/2012
1	ElectrolytesIBA 01/2012

Therapy/Procedure

1	Injections 11/2022
1	Oral Administration 08/2020
1	Traditional Medicine (Folk Remedies) 08/2016
1	Subcutaneous Injections 01/2015